These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9703853)

  • 41. Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot study.
    Isambert N; Correia M; Cercueil JP; Zanetta S; Osmak L; Flesch M; Krause D; Coudert B; Fargeot P; Bedenne L; Chauffert B
    J Exp Clin Cancer Res; 2001 Jun; 20(2):183-8. PubMed ID: 11484972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer].
    Xu RH; Guan ZZ; Jiang WQ; Huang H; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C; Ma ZY; Wang JH
    Ai Zheng; 2002 Dec; 21(12):1354-8. PubMed ID: 12520747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential advantages of loco-regional intra-arterial chemotherapy.
    Cagol PP; Pasqual E; Bacchetti S
    In Vivo; 2006; 20(6A):777-9. PubMed ID: 17203767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
    Rademaker-Lakhai JM; Terret C; Howell SB; Baud CM; De Boer RF; Pluim D; Beijnen JH; Schellens JH; Droz JP
    Clin Cancer Res; 2004 May; 10(10):3386-95. PubMed ID: 15161693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A new method of high-dose intraarterial chemotherapy of the pancreas using direct hemoperfusion (DHP) under portal venous isolation (PVI)].
    Tomioka M; Ku Y; Tominaga M; Kuroda Y; Saitoh Y
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2244-7. PubMed ID: 7944451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Efficacy of repeated hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Sim MK; Kim DY; Park JY; Kim JK; Kim SA; Ahn SH; Chon CY; Moon YM; Won JY; Lee DY; Han KH
    Korean J Hepatol; 2005 Sep; 11(3):268-74. PubMed ID: 16177553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver support systems: the low clearance of model hepatic excretory anions by charcoal hemoperfusion.
    Hew JT; Hart FE; Willson RA
    Gastroenterology; 1978 Apr; 74(4):661-3. PubMed ID: 631502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer.
    Yamamoto N; Tamura T; Kurata T; Yamamoto N; Sekine I; Kunitoh H; Ohe Y; Saijo N
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):79-88. PubMed ID: 19396598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin.
    Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
    Anticancer Res; 2005; 25(6C):4499-502. PubMed ID: 16334133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
    Kawase S; Okuda T; Ikeda M; Ishihara S; Itoh Y; Yanagawa S; Ishigaki T
    Gynecol Oncol; 2006 Sep; 102(3):493-9. PubMed ID: 16478629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection.
    Averbach A; Stuart OA; Chang D; Sugarbaker PH
    Eur J Surg Oncol; 2000 Feb; 26(1):73-9. PubMed ID: 10718184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK; Kwon YE
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma according to extrahepatic collateral feeding vessels].
    Jang BK; Chung WJ; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Choi JS; Kwon JH
    Korean J Hepatol; 2005 Dec; 11(4):359-70. PubMed ID: 16380665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH; Shi YX; Guan ZZ; Jiang WQ; Huang H; Ma ZY; Wang JH; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of intra-arterial chemotherapy on life prolongation in patients with hepatic metastasis from colorectal cancer].
    Mori K; Kosaka A; Watabiki Y; Yamada S; Ohara M; Yamazaki M; Shikata A; Hoshiya Y; Oohata K; Tukamoto H; Yoneyama Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1732-5. PubMed ID: 10560383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.